 Platinum Member (300+ posts)
Joined: Jun 2005 Posts: 349 Likes: 2 | Latest update on Tarceva:
WEDNESDAY NOVEMBER 02, 2005 Tarceva Gets FDA Okay for Pancreatic Cancer
SOUTH SAN FRANCISCO, Nov. 2 The FDA approved Tarceva (erlotinib) today as an oral therapy for advanced pancreatic cancer in combination with Gemzar (gemcitabine) chemotherapy, Genentech and OSI Pharmaceuticals announced.
Michael | 53 | SCC | Right Tonsil | Dx'd: 06-10-05 | STAGE IV, T3N2bM0 | 3 Nodes R Side | MRND & Tonsillectomy 06/29/05 Dr Fee/Stanford | 8 wks Rad/Chemo startd August 15th @ MSKCC, NY | Tx Ended: 09-27-05 | Cancer free at 16+ Yrs | After-Effects of Tx: Thyroid function is 0, ok salivary function, tinnitus, some scars, neck/face asymmetry, gastric reflux. 2017 dysphagia, L Carotid stent / 2019, R Carotid occluded not eligible for stent.2022 dental issues, possible ORN, memory/recall challenges.
| 
